Modernising Orodispersible Film Characterisation to Improve Palatability and Acceptability Using a Toolbox of Techniques.

3D printing acceptability bio-tribology disintegration testing mouthfeel orodispersible films

Journal

Pharmaceutics
ISSN: 1999-4923
Titre abrégé: Pharmaceutics
Pays: Switzerland
ID NLM: 101534003

Informations de publication

Date de publication:
29 Mar 2022
Historique:
received: 02 03 2022
revised: 19 03 2022
accepted: 28 03 2022
entrez: 23 4 2022
pubmed: 24 4 2022
medline: 24 4 2022
Statut: epublish

Résumé

Orodispersible films (ODFs) have been widely used in paediatric, geriatric and dysphagic patients due to ease of administration and precise and flexible dose adjustments. ODF fabrication has seen significant advancements with the move towards more technologically advanced production methods. The acceptability of ODFs is dependent upon film composition and process of formation, which affects disintegration, taste, texture and mouthfeel. There is currently a lack of testing to accurately assess ODFs for these important acceptability sensory perceptions. This study produced four ODFs formed of polyvinyl alcohol and sodium carboxymethylcellulose using 3D printing. These were assessed using three in vitro methods: Petri dish and oral cavity model (OCM) methods for disintegration and bio-tribology for disintegration and oral perception. Increasing polymer molecular weight (MW) exponentially increased disintegration time in the Petri dish and OCM methods. Higher MW films adhered to the OCM upper palate. Bio-tribology analysis showed that films of higher MW disintegrated quickest and had lower coefficient of friction, perhaps demonstrating good oral perception but also stickiness, with higher viscosity. These techniques, part of a toolbox, may enable formulators to design, test and reformulate ODFs that both disintegrate rapidly and may be better perceived when consumed, improving overall treatment acceptability.

Identifiants

pubmed: 35456566
pii: pharmaceutics14040732
doi: 10.3390/pharmaceutics14040732
pmc: PMC9029462
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : Engineering and Physical Sciences Research Council
ID : EP/L01646X/1

Références

Eur J Pharm Sci. 2015 Jul 30;75:2-9
pubmed: 25736528
Curr Res Food Sci. 2020 Nov 30;3:304-313
pubmed: 33336192
Biomed Res Int. 2014;2014:179568
pubmed: 25136560
ACS Appl Mater Interfaces. 2016 Oct 12;8(40):27199-27206
pubmed: 27648478
Int J Pharm. 2014 Aug 5;469(2):245-8
pubmed: 24704104
Curr Opin Food Sci. 2019 Jun;27:64-73
pubmed: 31903320
Ther Deliv. 2019 Jul;10(7):443-464
pubmed: 31264527
Int J Pharm. 2012 Mar 15;424(1-2):12-7
pubmed: 22240389
Phys Med Rehabil Clin N Am. 2008 Nov;19(4):691-707, vii
pubmed: 18940636
J Phys Colloid Chem. 1947 May;51(3):721-46
pubmed: 20238674
Pharmaceutics. 2012 Oct 26;4(4):551-62
pubmed: 24300370
Pharm Dev Technol. 2017 Mar;22(2):237-245
pubmed: 27346557
Int J Pharm. 2021 Feb 15;595:120197
pubmed: 33486041
J Mech Behav Biomed Mater. 2019 Feb;90:284-294
pubmed: 30391817
Food Sci Biotechnol. 2020 May 27;29(9):1233-1239
pubmed: 32802562
Eur J Pharm Biopharm. 2018 Apr;125:131-140
pubmed: 29355687
Drug Deliv. 2017 Nov;24(1):1243-1248
pubmed: 28856931
Pharmaceutics. 2021 Dec 17;13(12):
pubmed: 34959468
J Pharm Pharmacol. 2010 Apr;62(4):539-45
pubmed: 20604845
Food Funct. 2017 Feb 22;8(2):481-497
pubmed: 27775127
Expert Opin Drug Deliv. 2011 Mar;8(3):299-316
pubmed: 21284577
J Control Release. 2014 Jan 10;173:32-42
pubmed: 24184344
Eur J Pharm Biopharm. 2020 Jun;151:239-245
pubmed: 32348882
Dysphagia. 1992;7(4):187-200
pubmed: 1308667
J Pharm Sci. 2015 Nov;104(11):3893-903
pubmed: 26296236
Int J Pharm. 2020 Feb 15;575:118883
pubmed: 31811925
Pharmaceutics. 2021 Jul 22;13(8):
pubmed: 34452083
Int J Pharm Investig. 2013 Apr;3(2):67-76
pubmed: 24015378
Int J Clin Pharm. 2020 Apr;42(2):436-444
pubmed: 32052239
J Pharm Sci. 2019 May;108(5):1831-1836
pubmed: 30639737
Int J Pharm. 2015 Feb 20;479(2):277-81
pubmed: 25575471
Int J Pharm. 2017 May 15;523(1):327-335
pubmed: 28302515
Soft Matter. 2020 Dec 7;16(45):10290-10300
pubmed: 33047773
Eur J Pharm Biopharm. 2018 Nov;132:50-61
pubmed: 30201569
Int J Pharm. 2020 Jul 30;585:119532
pubmed: 32531448
Expert Opin Drug Deliv. 2016;13(4):493-506
pubmed: 26559519
Pharmaceutics. 2020 Jul 09;12(7):
pubmed: 32660030
Food Hydrocoll. 2018 Nov;84:173-180
pubmed: 30745713

Auteurs

Neel Desai (N)

Research Department of Pharmaceutics, UCL School of Pharmacy, University College London, London WC1N 1AX, UK.

Marc Masen (M)

Tribology Group, Department of Mechanical Engineering, Imperial College London, London SW7 9AG, UK.

Philippa Cann (P)

Tribology Group, Department of Mechanical Engineering, Imperial College London, London SW7 9AG, UK.

Ben Hanson (B)

UCL Mechanical Engineering, University College London, London WC1E 7JE, UK.

Catherine Tuleu (C)

Research Department of Pharmaceutics, UCL School of Pharmacy, University College London, London WC1N 1AX, UK.

Mine Orlu (M)

Research Department of Pharmaceutics, UCL School of Pharmacy, University College London, London WC1N 1AX, UK.

Classifications MeSH